CVE:MPH Medicure (MPH) Stock Price, News & Analysis C$0.94 -0.06 (-6.00%) As of 05/20/2025 10:14 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsBuy This Stock About Medicure Stock (CVE:MPH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Medicure alerts:Sign Up Key Stats Today's RangeC$0.94▼C$1.0050-Day RangeC$0.63▼C$1.0052-Week RangeC$0.63▼C$1.26Volume500 shsAverage Volume4,687 shsMarket CapitalizationC$9.81 millionP/E RatioN/ADividend Yield2.24%Price TargetN/AConsensus RatingN/A Company OverviewMedicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.Read More… Receive MPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter. Email Address MPH Stock News HeadlinesMedicure, Inc.: Medicure Announces Closing of Purchase Agreement for the Acquisition of Gateway Medical PharmacyMarch 11, 2025 | finanznachrichten.deTyreek Hill was driving an estimated 60 mph in a 40 mph zone before hectic detainment incidentSeptember 12, 2024 | nypost.comBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.May 24, 2025 | Golden Portfolio (Ad)Medicure Inc. (NGQ1.F)August 21, 2024 | uk.finance.yahoo.comMedicure Inc. (MPH.V)August 12, 2024 | ca.finance.yahoo.comMPH:CA Medicure Inc.July 26, 2024 | seekingalpha.comRochester, United States - Weather Forecasts | Maps | News - Yahoo WeatherMay 5, 2024 | yahoo.comCluj-Napoca, Romania - Weather Forecasts | Maps | News - Yahoo WeatherApril 24, 2024 | yahoo.comSee More Headlines MPH Stock Analysis - Frequently Asked Questions How have MPH shares performed this year? Medicure's stock was trading at C$0.88 at the beginning of the year. Since then, MPH stock has increased by 6.8% and is now trading at C$0.94. View the best growth stocks for 2025 here. How were Medicure's earnings last quarter? Medicure Inc. (CVE:MPH) announced its quarterly earnings results on Wednesday, May, 24th. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by $0.37. The company earned $8.71 million during the quarter, compared to the consensus estimate of $14.50 million. Medicure had a negative trailing twelve-month return on equity of 10.18% and a negative net margin of 9.65%. How do I buy shares of Medicure? Shares of MPH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Medicure own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medicure investors own include Dollarama (DOL), Alimentation Couche-Tard (ATD.B), Canoe EIT Income Fund (ENDTF), Allena Pharmaceuticals (ALNA), Hudbay Minerals (HBM), ProMetic Life Sciences (PLI) and Athersys (ATHX). Company Calendar Last Earnings5/24/2017Today5/23/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:MPH CIKN/A Webwww.medicure.com Phone+1-204-4877412FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.19) Trailing P/E RatioN/A Forward P/E Ratio14.40 P/E GrowthN/ANet IncomeC$-2,033,997.47 Net Margins-9.65% Pretax MarginN/A Return on Equity-10.18% Return on Assets-5.63% Debt Debt-to-Equity Ratio4.65 Current Ratio2.03 Quick Ratio1.29 Sales & Book Value Annual SalesC$21.08 million Price / Sales0.47 Cash FlowC$0.38 per share Price / Cash Flow2.49 Book ValueC$1.91 per share Price / Book0.49Miscellaneous Outstanding Shares10,436,300Free FloatN/AMarket CapC$9.81 million OptionableNot Optionable Beta0.90 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (CVE:MPH) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Makes Major Crypto AnnouncementYou Won’t Get a Second Chance at This Entry The crypto comeback isn't coming—it's already here. And one ...Crypto 101 Media | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicure Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.